お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の臨床試験サービス市場
市場調査レポート
商品コード
248889

世界の臨床試験サービス市場

Clinical Laboratory Services

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 365 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.74円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

世界の臨床試験サービス市場
出版日: 2021年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 365 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の臨床試験サービス市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 業界概要

  • 臨床試験サービス:概要
  • 特殊試験所の成長
  • 今後の見通し
  • 先進国:コストの圧力が新たな戦略を必要とする
  • 課題はあるが新興市場が成長の機会
  • 日常的試験がリードする
  • 主な市場成長促進因子
  • 高齢化による医療ニーズの拡大
  • 新興国における医療支出の増加
  • 意識レベルの向上
  • 医療費削減のニーズ
  • 疾患発症率の上昇
  • 感染症検査における臨床試験サービスの役割拡大

第3章 市場動向、課題

第4章 臨床試験サービス:イントロダクション

  • 医療試験所
  • 解剖病理学
  • 臨床病理学
  • 医療試験所で実施される試験の種類
  • 解剖病理学サービス
  • 臨床試験所の種類
  • 臨床試験所の作業工程
  • 検査試験所に続く経済的モデル

第5章 競合環境

  • 主要参入企業
  • サービス/製品導入
  • 近年の業界活動

第6章 世界市場見通し

第7章 地域別市場見通し

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ
  • その他の諸国

第8章 企業プロファイル

目次
Product Code: MCP-6952

Abstract:

The global market for Clinical Laboratory Services is projected to reach US$126.7 billion by 2024, driven by the rapidly growing test volumes compounded by aging population and the ongoing trend towards preventive healthcare. In addition to aging population, other factors responsible for the massive increase in patient specimens tested in labs and the ensuing demand for clinical lab testing services include increased diseases surveillance and screening supported by government public health screening policies; rise in new strains of infectious diseases; epidemic spread of chronic diseases such as diabetes, thyroid dysfunction and the need for routine diagnostics in long-term disease management; rise in cancer and robust demand for clinical molecular diagnostics to detect pathogenic mutations in DNA; and expanding base of state/local public and private health labs. Also driving growth in the market are several other factors such as increasing patient awareness over the importance of timely disease diagnosis; rising incidence of chronic conditions due to changing lifestyles; advancements in the area of proteomics and genomics; development of novel genetic tests, companion diagnostics and molecular testing; and rising CAPEX in affordable laboratory automation technologies. The growing focus shed on overall healthcare cost reduction is resulting in increased outsourcing of laboratory services. Outsourcing offers significant cost benefits for hospitals as it eliminates the need to invest in expensive laboratory automation equipment which is critical for timely processing of large volumes of patient samples in a single cycle without compromising analytical accuracy. The United States represents the largest market worldwide, supported by well-developed healthcare infrastructure, advancements in diagnostic services, and committed pursuit of excellence in diagnostic services. Asia-Pacific ranks as the fastest growing market with a CAGR of 8.3% through the analysis period led by vast unmet medical needs; high untapped potential due to lower current clinical testing levels; improving healthcare infrastructure; increasing income and healthcare per capita spending; growing prevalence of chronic and life-threatening diseases as a result of rapid economic growth, urbanization and the ensuing spread of unhealthy lifestyles; and the gradual transition to pro-healthy lifestyles.

Select Competitors (Total 125 Featured) -

  • ADICON Clinical Laboratories, Inc.
  • ARUP Laboratories
  • Bio-Reference Laboratories, Inc.
  • DaVita, Inc.
  • Enzo Clinical Labs
  • Genova Diagnostics, Inc.
  • Kingmed Diagnostics
  • Laboratory Corporation of America Holdings
  • Dynacare
  • Mayo Clinic Laboratories
  • NeoGenomics Laboratories
  • Genoptix, Inc.
  • Quest Diagnostics, Inc.
  • Sonic Healthcare Limited
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • American Esoteric Laboratories
  • SYNLAB International GmbH
  • The National Health Laboratory Service
  • Thyrocare Technologies Limited
  • Unilabs SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 Pandemic and Looming Global Recession
    • Clinical Laboratories Step Up Strategies for Protecting Personnel
    • Assays for COVID-19 Detection
    • Clinical Labs Benefit from the Surge in COVID-19 Testing Volumes
    • EXHIBIT 1: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of December 8th, 2020
    • COVID-19 Affects Fortunes of Non-COVID Diagnostics
    • Cancer Testing Dives During First Half of 2020
    • Labs Embark New Journeys to Retain Overall Volumes
    • At Home Testing Presents Challenges for Clinical Lab Services
    • An Introduction to Clinical Laboratory Services
    • Types of Tests Conducted in Medical Labs
    • Types of Clinical Laboratories
    • Global Market Prospects & Outlook
    • Hospital-based Laboratories Lead the Global Market
    • Developed Regions Lead, Developing Economies Present Considerable Growth Opportunities
    • Competition
    • Consolidation Activity Gathers Pace
    • Select M&A Transactions in Clinical Laboratory Services Industry (2019 & 2020)
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Healthcare Needs of Aging Population to Boost Demand for Laboratory Services
    • EXHIBIT 2: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 3: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • EXHIBIT 4: Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
    • Increasing Incidence of Chronic Diseases Drives the World Clinical Laboratory Services Market
    • EXHIBIT 5: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 6: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • EXHIBIT 7: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • EXHIBIT 8: Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Rise in Healthcare Expenditure to Drive Growth
    • EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • EXHIBIT 10: Elderly Healthcare Expenditure as a % of GDP
    • With COVID-19 Highlighting the Threat Posed by Infectious Diseases, Role of Clinical Labs in Testing Infectious Diseases Grows in Importance
    • EXHIBIT 11: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • EXHIBIT 12: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Increasing Prevalence of Respiratory Infections Drive Growth
    • EXHIBIT 13: Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Lab Automation Speeds Up
    • Rise of Laboratory 4.0 Transforms Clinical Laboratory Space
    • Laboratory Information Systems Gain Traction amidst Growing Need to Enhance Workflow Efficiencies and Reduce Costs
    • Artificial Intelligence: The Future of LIMS
    • Digitalization, Automation and AI Trends Shape Growth
    • Microbiology Laboratories Switch to Automation to Push Yields
    • EXHIBIT 14: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
    • Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
    • Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
    • Integration of Clinical Microbiology with Cloud Computing
    • Advent of New & Advanced Devices Fuels Growth in Clinical Laboratory Services Market
    • New Technologies and Tests Drive Demand for Specific Testing
    • Increasing Role of Advanced Tests in Clinical Treatment Decision Making
    • Innovations Hold Potential to Improve Clinical Chemistry Lab Performance
    • Disruptive Innovations in Clinical Lab Space Present Growth Opportunities
    • Increasing Opportunities in Personalized Medicine and Clinical Trial Services
    • EXHIBIT 15: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options
    • Genetic Disease Testing Offers Bright Prospects for Lab Services
    • Reduced Hospitalization Enhances Significance of Medical Labs
    • Standardization Gains Precedence in the Hunt for Automation
    • Assessing the Impact of Point-of-Care Testing on Clinical Labs
    • Hospital Laboratories to Transform into Profit Centers
    • Hospital Outreach Laboratories Deliver Better Value to Larger Organizations
    • Physician Office Laboratories: Focus on Reducing Turnaround Times for Testing
    • Emerging Clinical Laboratory Designs Focus on Improving Space Utilization and Promote Healthy Work Environments
    • Laboratory Outsourcing Trend Gains Strength
    • Challenges Facing Lab Testing Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Clinical Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 2: World Historic Review for Clinical Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 5: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Human & Tumor Genetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 8: World Historic Review for Human & Tumor Genetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Human & Tumor Genetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Medical Microbiology & Cytology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 11: World Historic Review for Medical Microbiology & Cytology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Medical Microbiology & Cytology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 14: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 17: World Historic Review for Hospital-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Hospital-based Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Independent Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 20: World Historic Review for Independent Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Independent Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Physician Office-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 23: World Historic Review for Physician Office-based Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Physician Office-based Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

    • GEOGRAPHIC MARKET ANALYSIS
    • UNITED STATES
    • United States: A Major Market for Clinical Laboratory Services
    • A Glance at Major Growth Drivers
    • COVID-19 Accelerates Market Expansion
    • US-based Labs Ramp Up Operations Amidst the COVID-19 Situation
    • FDA Plays Instrumental Role in Influx of New Tests
    • CMS Prioritizes COVID-19 Testing: Announces New Reimbursement Rules
    • Unmet Diagnostic Needs of Aging Population: Major Driver
    • EXHIBIT 16: US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • Increasing Burden of Chronic Diseases Drives Focus onto Early Detection & Prevention
    • Cancer Statistics in the US
    • EXHIBIT 17: Leading Sites of New Cancer Cases in Males: 2020
    • EXHIBIT 18: Leading Sites of New Cancer Cases in Females: 2020
    • Prevalence of Diabetes in the US
    • EXHIBIT 19: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
    • Opportunities in Personalized Medicine and Clinical Trial Services
    • Growing Focus on Early Diagnosis
    • Impact of Scientific Advances & Role of Healthcare IT Solutions
    • Need to Reduce Healthcare Costs
    • Opportunities from Individual Testing & Population Screening Initiatives
    • Clinical Laboratory Services: Systemic Challenges
    • Changing Healthcare Industry Dynamics Affect Clinical Lab Testing Market
    • EXHIBIT 20: Healthcare Spending as a % of GDP in the US: 2010-2020
    • Key Trends & Issues
    • Anatomic Pathology & Cytology Testing: Personalized Medicine Presents Positive Future
    • Esoteric Testing Market: Faster Growth than Routine Testing Segment
    • Molecular Diagnostics: Promising Growth Opportunities
    • Drugs of Abuse Testing: Prospects Linked to Employment Levels
    • Future Holds Promise for Specialty Testing Market
    • Smaller Labs Embrace Digital Pathology Systems
    • Impact of Healthcare Spending Cuts on Routine & Specialty Lab Tests
    • Increasing Role of Advanced Tests in Clinical Treatment Decision Making
    • Toxicology Laboratories Market: An Insight
    • Genetic and Genomic Clinical Lab Testing Market: Promising Prospects
    • Shift towards Managed Care - A Challenge for Independent Clinical Labs?
    • ACO Business Model: A Challenge for Independent Labs
    • Integration of Clinical Care: Impact on Clinical Labs & Anatomic Pathology Groups
    • Hospital Laboratory Outreach Programs: On the Rise
    • Physician Practices: The New Acquisition Targets
    • EXHIBIT 21: % of Independent Physicians in the US (2000, 2005 & 2018)
    • Cost Cutting Measures to Hit Lab Outreach Testing Business?
    • Shortened Hospital Stay Enhances Significance of Medical Labs
    • POCT Segment Withstands Cost Pressures
    • Quality Concerns Bring IT Solutions & Automation to the Fore
    • Move towards IQCP
    • Reimbursement Policies Strongly Influence Clinical Lab Services Market
    • Challenges Facing Clinical Labs Market
    • Competitive Landscape
    • Providers of Clinical Laboratory Service in the US: A Review
    • Hospital-Based Labs
    • EXHIBIT 22: Registered Hospitals in the US by Type: 2018
    • Independent Labs
    • EXHIBIT 23: Independent Labs Market in the US (2019): Percentage Share Breakdown of Revenues for Quest Diagnostics, LabCorp, Small Independent Labs and Others
    • Physician Office-Based Labs and Others
    • Consolidation Activity Gathers Pace in Clinical Laboratory Testing Market
    • Accreditation and Regulatory Scenario in the US
    • Clinical Laboratory Improvement Amendments (CLIA)
    • EXHIBIT 24: CLIA Laboratories Registered: March 2020
    • A2LA
    • ASCLS
    • CAP
    • An Overview of Select Regulations
    • Protecting Access to Medicare Act (PAMA) of 2014
    • Health Insurance Portability and Accountability Act of 1996
    • Substance Abuse and Mental Health Services Administration (SAMHSA) Regulation
    • Medicare Coverage for Screening Tests
    • EXHIBIT 25: Medicare Spending in the US by Category (2019): Percentage Share Breakdown of Spending for Medicare Advantage, Inpatient Hospital, Prescription Drugs, Physician Fee Schedule, Outpatient Hospital and Others
    • Medicaid
    • Market Analytics
    • TABLE 25: USA Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 26: USA Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 27: USA 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 30: USA 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • CANADA
    • COVID-19 Widens the Business Case for Clinical Laboratory Services
    • Market Analytics
    • TABLE 31: Canada Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 32: Canada Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 33: Canada 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 35: Canada Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 36: Canada 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • JAPAN
    • COVID-19 Testing Elevates Market Prospects
    • Market Analytics
    • TABLE 37: Japan Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 38: Japan Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 39: Japan 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 41: Japan Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 42: Japan 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • CHINA
    • Clinical Laboratory Services Market in China: An Overview
    • COVID-19 Outbreak Spurs Huge Demand
    • Healthcare Reforms Bolster Opportunities
    • Independent Clinical Labs Gain from Prevailing Trends
    • EXHIBIT 26: Leading Independent Medical Labs in China (2019): Percentage Breakdown of Revenues for Leading Players
    • Market Leaders Look to Expand Beyond Clinical Services
    • CNAL: The National Accreditation Body in China
    • Market Analytics
    • TABLE 43: China Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 44: China Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 45: China 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 47: China Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 48: China 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • EUROPE
    • Market Overview
    • COVID-19 Testing Drives Revenue Growth
    • Aging Population: Prime Growth Driver
    • Automated Systems Gain Preeminence
    • Accreditation and Regulatory Scenario in the EU
    • Market Analytics
    • TABLE 49: Europe Current & Future Analysis for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 50: Europe Historic Review for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 51: Europe 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 53: Europe Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 54: Europe 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 56: Europe Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 57: Europe 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • FRANCE
    • TABLE 58: France Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 59: France Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 60: France 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 62: France Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 63: France 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • GERMANY
    • Clinical Laboratory Services in Germany: An Overview
    • Regulatory/Accreditation Scenario
    • Market Analytics
    • TABLE 64: Germany Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 65: Germany Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 66: Germany 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 68: Germany Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 69: Germany 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • ITALY
    • TABLE 70: Italy Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 71: Italy Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 72: Italy 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 74: Italy Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 75: Italy 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • UNITED KINGDOM
    • Market Overview
    • COVID-19 Testing in the UK
    • Market Analytics
    • TABLE 76: UK Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 77: UK Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 78: UK 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 80: UK Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 81: UK 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • SPAIN
    • TABLE 82: Spain Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 83: Spain Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 84: Spain 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 85: Spain Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 86: Spain Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 87: Spain 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • RUSSIA
    • TABLE 88: Russia Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 89: Russia Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 90: Russia 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 91: Russia Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 92: Russia Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 93: Russia 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 95: Rest of Europe Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 96: Rest of Europe 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 98: Rest of Europe Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 99: Rest of Europe 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • ASIA-PACIFIC
    • Asia-Pacific: An Emerging Market
    • Market Analytics
    • TABLE 100: Asia-Pacific Current & Future Analysis for Clinical Laboratory Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 101: Asia-Pacific Historic Review for Clinical Laboratory Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 102: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 104: Asia-Pacific Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 105: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 107: Asia-Pacific Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 108: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • AUSTRALIA
    • TABLE 109: Australia Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 110: Australia Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 111: Australia 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 112: Australia Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 113: Australia Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 114: Australia 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • INDIA
    • India: High Growth Market
    • Clinical Laboratory Market: Overview
    • COVID-19 Testing Widens Opportunities
    • Levels of Medical Laboratories
    • Competitive Landscape
    • Market Analytics
    • TABLE 115: India Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 116: India Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 117: India 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 118: India Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 119: India Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 120: India 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • SOUTH KOREA
    • COVID-19 Steers Clinical Lab Services Market
    • Market Analytics
    • TABLE 121: South Korea Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 122: South Korea Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 123: South Korea 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 124: South Korea Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 125: South Korea Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 126: South Korea 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 128: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 131: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • LATIN AMERICA
    • TABLE 133: Latin America Current & Future Analysis for Clinical Laboratory Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 134: Latin America Historic Review for Clinical Laboratory Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 135: Latin America 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 137: Latin America Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 138: Latin America 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 140: Latin America Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 141: Latin America 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • ARGENTINA
    • TABLE 142: Argentina Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 143: Argentina Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 144: Argentina 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 145: Argentina Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 146: Argentina Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 147: Argentina 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • BRAZIL
    • TABLE 148: Brazil Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 149: Brazil Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 150: Brazil 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 151: Brazil Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 152: Brazil Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 153: Brazil 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • MEXICO
    • TABLE 154: Mexico Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 155: Mexico Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 156: Mexico 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 157: Mexico Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 158: Mexico Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 159: Mexico 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 161: Rest of Latin America Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 162: Rest of Latin America 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 163: Rest of Latin America Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 164: Rest of Latin America Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 165: Rest of Latin America 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • MIDDLE EAST
    • TABLE 166: Middle East Current & Future Analysis for Clinical Laboratory Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
    • TABLE 167: Middle East Historic Review for Clinical Laboratory Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 168: Middle East 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 170: Middle East Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 171: Middle East 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 173: Middle East Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 174: Middle East 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • IRAN
    • TABLE 175: Iran Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 176: Iran Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 177: Iran 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 178: Iran Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 179: Iran Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 180: Iran 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • ISRAEL
    • TABLE 181: Israel Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 182: Israel Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 183: Israel 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 184: Israel Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 185: Israel Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 186: Israel 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • SAUDI ARABIA
    • TABLE 187: Saudi Arabia Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 188: Saudi Arabia Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 189: Saudi Arabia 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 190: Saudi Arabia Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 191: Saudi Arabia Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 192: Saudi Arabia 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • UNITED ARAB EMIRATES
    • TABLE 193: UAE Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 194: UAE Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 195: UAE 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 196: UAE Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 197: UAE Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 198: UAE 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • REST OF MIDDLE EAST
    • TABLE 199: Rest of Middle East Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 200: Rest of Middle East Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 201: Rest of Middle East 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 202: Rest of Middle East Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 203: Rest of Middle East Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 204: Rest of Middle East 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027
    • AFRICA
    • TABLE 205: Africa Current & Future Analysis for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 206: Africa Historic Review for Clinical Laboratory Services by Test Type - Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 207: Africa 15-Year Perspective for Clinical Laboratory Services by Test Type - Percentage Breakdown of Value Revenues for Clinical Chemistry, Human & Tumor Genetics, Medical Microbiology & Cytology and Other Test Types for the Years 2012, 2020 & 2027
    • TABLE 208: Africa Current & Future Analysis for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
    • TABLE 209: Africa Historic Review for Clinical Laboratory Services by Service Provider - Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
    • TABLE 210: Africa 15-Year Perspective for Clinical Laboratory Services by Service Provider - Percentage Breakdown of Value Revenues for Hospital-based Laboratories, Independent Laboratories and Physician Office-based Laboratories for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 129
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.